It has recently been shown that neurofibromatosis 1 (NF1) is associated with a defect in the neurofibromin gene on chromosome 17
The aims of our study were to clarify the clinical characteristics of spinal neurofibromas; to identify the main differences between spinal neurofibromas and schwannomas; and to determine long-term outcomes for patients with spinal neurofibromas, both sporadic and NF1 associated.
Clinical Material and Methods
A screening of medical files for patients with spinal tumors operated on between 1953 and 1985 at the Department of Neurosurgery, Helsinki University Hospital, identified 296 patients with a suspected nerve sheath tumor. Two hundred eighty-three histological specimens from these patients were made available to us for reexamination. New paraffin sections were cut and stained using the hematoxylin and eosin and van Gieson methods. The reexamination was performed by a neuropathologist (M.J.J.H.) who identified 32 neurofibromas, 187 schwannomas, eight cellular schwannomas, six malignant nerve sheath tumors, and 50 other neoplasms or nonneoplastic lesions. A report covering the cellular schwannomas and malignant nerve sheath tumors has already been published. 22 The hospital records for the 32 patients with spinal neurofibromas were surveyed for all clinical data. This retrospective analysis identified 22 patients with clinical NF1. The present addresses or dates of death of the patients were obtained from the Population Register Centre of Finland, and copies of the patients' death certificates were supplied by Statistics Finland. A detailed questionnaire was sent to all living patients. Two patients were lost to follow up, one after 4 months and the other after 7 months. Additional information was obtained from other hospitals in which the patients had been treated for this or other conditions. The follow-up investigation was completed at the end of 1992.
Statistical calculations were made with a commercially available statistical software package.* The MannWhitney U-test and the Student's t-test were used for comparisons. Relative survival rates were calculated using a special computer package. 4 Expected survival rates were derived from the age-, sex-and calendar period-specific rates of the general population of Finland.
Results

Histopathological Findings
The spinal tumors identified in 16 NF1 patients were typical neurofibromas showing Schwann cells, fibroblastlike cells, and abundant collagen fibers, partially organized in bundles (Fig. 1) . Four patients had plexiform neurofibromas, and these tumors were characteristically situated in the lower cervical region and growing into the brachial plexus. Eight non-NF1 patients had conventional neurofibromas. Tumors found in two NF1 and two non-NF1 patients contained areas resembling schwannoma in addition to typical neurofibroma appearance.
Patient Characteristics
Basic data on the 32 patients are presented in Table 1 .
Twenty-two patients were diagnosed as having NF1. In 12 of these cases the diagnosis had been made earlier and in six it was made in connection with the preoperative examination. In four cases the development of additional manifestations of NF1 yielded the diagnosis at a later date. Ten patients showed no other hallmarks of NF1; these cases of neurofibromas were judged to be sporadic occurrences.
Of the patients with NF1, there were 13 females and nine males ( Table 1 ). The median age for all males in the study was 35.5 years and for all females 29.5 years. Median ages for patients with NF1 were 31.0 and for non-NF1 patients 34.0 years. The age distribution did not differ between either group. Three NF1 patients and one non-NF1 patient were below 16 years of age.
Clinical Presentation
There was no difference between NF1 and non-NF1 patients in the quality, severity, or duration of preoperative symptoms ( Table 2 ).
The primary presenting symptom was progressive paraparesis due to medullary compression in 14 patients and localized or radiating pain in seven patients. Nine patients, six of whom had NF1, were unable to walk on admission. Two non-NF1 patients were totally paraplegic. The duration of symptoms varied from 6 weeks to more than 5 years. One patient (Case 10) with known NF1 had no symptoms, and the tumor was found incidentally in a plain film of the cervical spine.
The symptoms correlated to some extent with the level of the tumor. All 11 upper cervical tumors caused at least some degree of paraparesis because of medullary compression. Seven of the 10 lower cervical tumors caused radicular pain and seven also produced symptoms of medullary compression. Thoracic tumors presented with pain and progressive paraparesis and lumbar tumors with a radicular pain-mimicking sciatica. Bladder paresis was associated with three upper cervical, two lower cervical, and two multiple tumors.
Radiographic Examination
Plain x-ray films of the spine appeared normal in seven patients, four of whom had clinical NF1. Enlargement of an intervertebral foramen was seen in 13 NF1 and three non-NF1 patients. Narrowing of the pedicle occurred in two NF1 and one non-NF1 patient. Scalloping of the corpus was seen in one patient in each group.
Myelography showed a tumor shadow in 17 cases, 12 of which were cases of NF1. A total block was seen in six patients with NF1 and two without. Two myelograms were nondiagnostic. Aggravation of symptoms due to myelography occurred in one case. Computerized tomography scans were obtained in three patients. At the time these tumors were treated magnetic resonance (MR) imaging was not available.
Cerebrospinal Fluid Findings
Lumbar puncture to obtain cerebrospinal fluid had been performed on 18 patients. The mean protein concentration was 1768 mg/100 ml (range 210 mg/100 ml to 6600 mg/100 ml).
Spinal neurofibroma outcome * Medstat statistical software package available from Astra, Copenhagen, Denmark. 
Operative Findings and Outcomes
Tumor removal using either a single operation or a twostage procedure was total in 26 cases and partial in six. At operation 21 tumors (66%) were found to grow both extra-and intradurally, 14 of these in NF1 patients. Seven tumors (22%) were totally intradural and four (12%) totally extradural. Extension out from the spinal canal through the intervertebral foramen was seen in 17 patients (53%), 13 of whom had NF1. All tumors were attached to at least one nerve root and one tumor was also attached to the spinal cord. All tumors were situated laterally or lateroventrally in the spinal canal.
The root from which the tumor originated had to be sectioned in 24 cases (75%). Two or more roots were sacrificed in five cases (16%). In two cases the tumor could be removed with partial preservation of the root. The fate of the root was not mentioned in one operative record.
After the operation 22 patients (69%) improved neurologically, four (12%) remained unchanged, and five (16%) deteriorated. Both patients with preoperative paraplegia remained paraplegic. There was one operative fatality in the case of a young man (Case 27) with an upper cervical tumor that caused severe tetraparesis.
Follow-Up Examinations
Seven NF1 patients presented with a second symptomatic spinal neurofibroma during follow-up examinations. In four of these cases the second tumor was removed and in three cases in which the symptoms were mild, treatment was expectant. Multiple new tumors were observed in four patients. Recurrence of the original spinal neurofibroma was seen in four patients. Three NF1 patients experienced recurrence after partial removal of the primary tumor; the fourth patient with no peripheral hallmarks of NF1 developed a symptomatic recurrence at the original site 5 years after a seemingly total removal of the primary tumor.
Other late complications were the development of a spinal deformity in two NF1 patients (Cases 7 and 12) and severe dysesthesia in two patients (Cases 3 and 31).
The principal causes of death are shown in Table 3 . The 5-, 10-and 15-year relative cumulative survival rates for the neurofibroma patients were 81%, 62%, and 53%, respectively (Fig. 2) .
Clinical State
Of the fifteen patients alive at the end of follow up, only one considered herself free of symptoms. Eight patients (53%) suffered from localized neck or back pain and six (40%) from pain radiating segmentally. One patient complained of severe dysesthetic pain.
A mild dermatomal sensory deficit was present in six patients (40%), all of whose nerve roots had been sectioned at operation. A preoperative sensory deficit had been present in two. A truncal sensory level deficit was observed in one NF1 patient with an upper cervical tumor.
A mild motor weakness caused by a lesion of the innervating nerve root was present in five patients (33%). Radicular motor weakness was present in three of these patients preoperatively. Improvement of radicular motor function compared to the preoperative level had occurred in five patients.
Fourteen patients were ambulatory; nine patients (60%), six of whom had NF1, walked normally. A moderate para-or tetraparesis was present in two NF1 and one non-NF1 patient. One young tetraparetic boy (Case 22) with spinal NF1 18 and multiple recurrent tumors in the cervical region suddenly deteriorated to a vegetative state 2 years after the last operation, probably because of a pontine infarction.
One NF1 and one non-NF1 patient have difficulties emptying their bladder.
Of the two NF1 patients with partial removal of their primary tumor, one (Case 10) had occasional localized neck pain but no other symptoms almost 5 years after the operation. No neuroradiology had been performed in this patient. The other patient (Case 14) underwent MR imaging of the lumbar spine 7 years after the primary operation; multiple neurofibromas on several roots were found including an obvious recurrence.
Six patients (40%), three with NF1, continued in their preoperative occupations; five (33%), all with NF1, were unable to work; and three (20%), two with NF1, had retired due to advanced age. The occupational status of one patient was unknown.
Discussion
Neurofibromatosis 1 (von Recklinghausen's disease), 27 an autosomal dominantly inherited condition, occurs in approximately one of 4000 live births. 16 It predisposes to peripheral and central neurofibromas and is associated with a defect of the neurofibromin gene on chromosome 17. 1, 14 Spinal neurofibromas also occur in patients without clinical signs of NF1, and these are considered sporadic occurrences. 20 As long as there is no routine screening method for identifying patients carrying the NF1 gene, there will always be some uncertainty as to whether a patient with a single neurofibroma represents a true sporadic case or carries the defective gene with only mild clinical penetration.
In our series two-thirds of the patients were clinically judged to be cases of NF1 and one-third were considered sporadic cases of spinal neurofibroma. Both patient groups turned out to be quite similar. The median age at diagnosis of the spinal tumor did not differ between NF1 and non-NF1 patients, although both groups were younger than patients with spinal schwannomas, whose median age at presentation is in the fifth decade. 7, 19 The symptoms and signs in both groups were also similar.
The distribution of tumors along the spinal axis was equal in both patient groups. In our series 66% of the neurofibromas were located in the cervical region. Most spinal tumors, including schwannomas, are distributed evenly along the spinal canal. 17, 24 In reports presented by Levy, et al., 11 Salah, et al., 19 and Iraci and colleagues 9 the authors state that 30%, 34%, and 37%, respectively, of the spinal "neurinomas" investigated were cervical. Hori and colleagues 7 reported a cervical predilection for spinal "neurinomas" in their study of 45 patients and Halliday, et al., 5 reported one for spinal neurofibromas. These reports correspond to our findings. In the report by Lusk, et al., 13 more than one-half of tumors of the brachial plexus were neurofibromas. In our investigation four lower cervical tumors extended into the plexus and had to be removed using both intra-and extraspinal approaches. Two-thirds of the spinal neurofibromas in our series grew transdurally. This type of growth was seen in both NF1 and non-NF1 patients and is probably common for neurofibromas, although it was seen in only one of four tumors presented by Sanguinetti, et al. 20 Spinal schwannomas, on the contrary, are mostly intradural, extramedullary tumors. 7, 19 The rate of transdurally growing hourglass schwannomas is approximately 15%. 11, 17 Approximately 2% of patients affected with NF1 will develop symptomatic spinal tumors. 8 The most common complication we found in this study was the development of a second spinal neurofibroma, which occurred in seven patients. It seems that NF1 patients with a spinal neurofibroma bear a high risk of developing a second tumor within the coming years, and thus these patients warrant close clinical follow up. Magnetic resonance imaging of patients with NF1 has shown that asymptomatic spinal and paraspinal neurofibromas are common. 3 Routine MR screening of these patients is probably not advisable as long as the treatment of choice is removal of symptomatic neurofibromas. All neurofibromas that are identified radiologically will probably never reach a size that would produce symptoms.
Sørensen and colleagues 23 found a reduced life expectancy and a fourfold risk of developing benign or malignant tumors in a population study of NF1 patients. Our patients with spinal neurofibromas had a considerably higher rate of long-term mortality compared to a matched general population, regardless of the presence or absence of other hallmarks of NF1 (Table 3 ). In three cases the principal cause of death was neurofibromatosis without further specification. Intracranial tumors accounted for two deaths. One patient died of a malignant neurofibrosarcoma and one of intestinal occlusion, possibly as a consequence of intestinal neurofibromatosis. 12 The observed excess in mortality among non-NF1 patients probably reflects the poor neurological condition of some of the patients.
Sectioning of the nerve root at the time of removal of a nerve sheath tumor leads to a neurological deficit in only a minority of cases. 10, 21 In the fifteen patients who were alive at follow up, a postoperative sensory deficit had occurred in four. In all cases it was mild. Interestingly, a mild radicular sensory deficit disappeared in one patient after the operation. A mild postoperative radicular motor weakness occurred in two patients and improvement in radicular motor function occurred in five patients. It has been hypothesized that nerve sheath tumors develop on clinically nonfunctional roots, which would explain the lack of deficits after root sectioning. 10 This theory, however, cannot explain the improvement of function seen in some patients. It seems likely that some clinical symptoms may result from compression of neighboring roots and when this compression is relieved, improvement begins. This would also explain why recovery may take several months.
No population-based incidence figures for spinal neurofibromas have been published. Spinal "neurinomas" comprise approximately 25% of spinal tumors. 17 Hori, et al., 7 observed seven neurofibromas among 45 "neurinomas," a rate of 15.6%. In our study we found 32 neurofibromas among 233 spinal tumors of nerve sheath origin, a rate of 13.7%. Thus spinal neurofibromas constitute approximately 3.5% of the total number of spinal tumors.
Spinal neurofibroma is a specific entity that differs in many aspects from spinal schwannoma (Table 4 ). In many cases it is associated with NF1 and its occurrence may herald other manifestations of the disease.
Addendum
After the acceptance of this manuscript, reoperation was undertaken in Case 14 for the patient's symptomatic, now extradural, recurrent neurofibroma. A gross total removal was performed 10 years after the primary operation, with excellent outcome.
